HSP90-IN-13 is a potent pan-HSP90 inhibitor (IC50 = 25.07 nM) with multi-target activity against EGFR, VEGFR-2, and Topoisomerase-2; it induces G2/M phase cell cycle arrest in MCF-7 cells and triggers apoptosis via the mitochondrial-mediated pathway.